Presentation is loading. Please wait.

Presentation is loading. Please wait.

Collecting Site Positivity Data in Region I Andee Krasner, MPH Region I IPP Advisory Board Meeting.

Similar presentations


Presentation on theme: "Collecting Site Positivity Data in Region I Andee Krasner, MPH Region I IPP Advisory Board Meeting."— Presentation transcript:

1 Collecting Site Positivity Data in Region I Andee Krasner, MPH Region I IPP Advisory Board Meeting

2 Background In 2006, Region I began collecting only IPP- funded CT testing data In 2010, CDC requested that the Infrastructure begin process of collecting site CT data, not just IPP-funded CT Testing 2

3 Goals With minimum burden to IPP AB Members, collect site positivity for IPP-funded sites and report to CDC Make site positivity data available through state IPP Prevalence Monitoring System for use at state and local level 3

4 CSPS- 3% Minimum CSPS guidance assumes site positivity, not IPP positivity Not known how IPP positivity rates compare to site positivity If you have site positivity data, you should use it to determine 3% minimum positivity requirements for CSPS May use IPP positivity rates for CSPS until site positivity project is complete 4

5 Plan for Collecting Site Positivity Work with State STD Directors and Lab Directors to request data extracts for data already collected by the state Work with STD Directors and Family Planning Directors to request data from private labs Develop systems for feeding site positivity data back into Prevalence Monitoring Data Systems 5

6 Requested Data Fields Request limited dataset from Labs: Medical Record # / (Lab ID # will be ok) Test Facility ID State of Client residence (zip is ok) Age (DOB is ok) Gender Test for CT and/or GC Test result Date of test performed Nice to have: Race/Ethnicity Clinical History (source, pregnant, routine exam) Payment Risk History 6

7 Progress RI – provided data extract for all tests from IPP sites PPNNE – provided data extract from all PPNNE IPP sites in VT, NH and ME NH State Lab going to an electronic reporting system. They will provide extract of all state- funded tests at IPP sites. 7

8 Next Steps Non-IPP funded tests received – Develop a system for feeding data back into state Prevalence Monitoring System Work with AB Members to request limited dataset from IPP sites 1.New Hampshire 2.Maine 3.Connecticut 4.Massachusetts 8


Download ppt "Collecting Site Positivity Data in Region I Andee Krasner, MPH Region I IPP Advisory Board Meeting."

Similar presentations


Ads by Google